Assessment of competition, (competitive) therapeutic environment or unmet clinical conditions
Acquisition and contact with key opinion leaders (KOLs), medical/scientific societies and patient support and advocate groups
Advice on the legal framework conditions for use of medicines, distribution, marketing, sales and reimbursement
Detailed written reports on pricing and reimbursement
Specialized consulting for unapproved medicine including therapy on name patient basis
Support in meeting with local authorities, i.e.:
· BfArM (Bundesamt für Arzneimittel und Medizinprodukte), · German Drug Agency · PEI (Paul-Ehrlich-Institut), German Drug Agency responsible for · vaccines and biomedical medicines
Advice on distribution channels including contract formation with competent logistic business partners
Advice of and arrangements for formation of local branches, i.e. GmbH (Ltd.)
Marketing plans, launch plans and direct support of product launches, detailed to fit niche products, Orphan Drugs etc.
For special questions and problems, please contact us without obligation: